Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
2.
Bioinspir Biomim ; 6(3): 036008, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21865627

RESUMEN

We present an unsteady blade element theory (BET) model to estimate the aerodynamic forces produced by a freely flying beetle and a beetle-mimicking flapping wing system. Added mass and rotational forces are included to accommodate the unsteady force. In addition to the aerodynamic forces needed to accurately estimate the time history of the forces, the inertial forces of the wings are also calculated. All of the force components are considered based on the full three-dimensional (3D) motion of the wing. The result obtained by the present BET model is validated with the data which were presented in a reference paper. The difference between the averages of the estimated forces (lift and drag) and the measured forces in the reference is about 5.7%. The BET model is also used to estimate the force produced by a freely flying beetle and a beetle-mimicking flapping wing system. The wing kinematics used in the BET calculation of a real beetle and the flapping wing system are captured using high-speed cameras. The results show that the average estimated vertical force of the beetle is reasonably close to the weight of the beetle, and the average estimated thrust of the beetle-mimicking flapping wing system is in good agreement with the measured value. Our results show that the unsteady lift and drag coefficients measured by Dickinson et al are still useful for relatively higher Reynolds number cases, and the proposed BET can be a good way to estimate the force produced by a flapping wing system.


Asunto(s)
Aeronaves , Materiales Biomiméticos , Biomimética/instrumentación , Biomimética/métodos , Escarabajos/fisiología , Vuelo Animal/fisiología , Alas de Animales/fisiología , Animales , Simulación por Computador , Diseño Asistido por Computadora , Diseño de Equipo , Análisis de Falla de Equipo , Miniaturización , Modelos Biológicos , Estrés Mecánico
3.
Br J Cancer ; 79(5-6): 814-20, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10070874

RESUMEN

Pre-clinical evaluation has demonstrated that 2-[4-(((3,5-dimethylanilino)carbonyl)methyl)phenoxy]-2-methylpropi onic acid (RSR13) acts as an allosteric effector of haemoglobin (Hb). RSR13 binding to Hb results in decreased haemoglobin-oxygen (Hb-O2) affinity, improved tumour oxygenation, and enhanced radiation-induced cell killing in several experimental tumour systems. In the present work, ex vivo clonogenic survival analyses are applied in two murine tumour systems to characterize the relationship between the magnitude of decrease in Hb-O2 affinity and radiosensitization, the influence of inspired pO2 upon this effect, and the efficacy of combining RSR13 and radiation during a course of repeated radiation exposures. For FSaII tumours in C3H mice breathing air, 100 mg kg(-1) RSR13 administered intraperitoneally produced an enhancement ratio (ER) of 1.3, but there was marked desensitization at a RSR13 dose of 300 mg kg(-1) (ER 0.6). The most likely reason for the increased radioresistance was insufficient oxygen loading of Hb in the pulmonary circulation due to reduced haemoglobin-oxygen affinity because carbogen breathing combined with 300 mg kg(-1) RSR13 reversed the effect and produced an ER of 1.8. In SCCVII tumours in C3H mice irradiated with eight fractions of 2.5 Gy over 4 days, the surviving fraction was reduced to 58-67% of control values when RSR13 was combined with radiation on days 1 and 2, days 3 and 4, or days 1-4. These results confirm that combining RSR13 and irradiation within a fractionated course of clinically relevant low-dose exposures provides significant radiosensitization. Additional preclinical experimentation is needed to define better the optimum dose-scheduling conditions for clinical applications.


Asunto(s)
Compuestos de Anilina/uso terapéutico , Dióxido de Carbono/uso terapéutico , Carcinoma de Células Escamosas/radioterapia , Fibrosarcoma/radioterapia , Oxígeno/uso terapéutico , Propionatos/uso terapéutico , Fármacos Sensibilizantes a Radiaciones/uso terapéutico , Regulación Alostérica , Compuestos de Anilina/farmacocinética , Compuestos de Anilina/toxicidad , Animales , Antidrepanocíticos/farmacocinética , Antidrepanocíticos/toxicidad , Dióxido de Carbono/toxicidad , Carcinoma de Células Escamosas/patología , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/efectos de la radiación , Radioisótopos de Cobalto , Fibrosarcoma/patología , Hemoglobinas/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C3H , Oxígeno/toxicidad , Oxihemoglobinas/efectos de los fármacos , Propionatos/farmacocinética , Propionatos/toxicidad , Circulación Pulmonar , Ensayo de Tumor de Célula Madre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA